Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
Agnico Eagle Mines Ltd
TSX:AEM
|
CA |
|
F
|
Fluor Corp
SWB:FLU
|
US |
|
P
|
Pioneer Natural Resources Co
LSE:0KIX
|
US |
|
Cass Information Systems Inc
NASDAQ:CASS
|
US |
|
A
|
Aboitiz Power Corp
OTC:ABZPY
|
PH |
|
S
|
Savills PLC
F:1YZ
|
UK |
|
Powersoft SpA
MIL:PWS
|
IT |
|
Sherwin-Williams Co
NYSE:SHW
|
US |
|
Butterfly Network Inc
NYSE:BFLY
|
US |
|
ActiveOps PLC
LSE:AOM
|
UK |
|
C
|
CNOOC Ltd
F:NC2A
|
CN |
|
Viscofan SA
MAD:VIS
|
ES |
|
Spire Global Inc
F:43J
|
US |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
C
|
Champion Iron Ltd
F:MMPI
|
AU |
|
Alamos Gold Inc
TSX:AGI
|
CA |
|
Grail Inc
F:NL0
|
US |
|
D
|
DXP Enterprises Inc
F:DX7
|
US |
Shareholder Yield
Current shareholder yield for BMRN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BMRN Price
Biomarin Pharmaceutical Inc
| Average Annual Return | -2.44% |
| Standard Deviation of Annual Returns | 21.06% |
| Max Drawdown | -58% |
| Market Capitalization | 11.5B USD |
| Shares Outstanding | 193 280 000 |
| Percentage of Shares Shorted | 7.22% |
